Patents by Inventor Lauren Marie Tatalick

Lauren Marie Tatalick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS TO INHIBIT OR AUGMENT AN INFLAMMATORY RESPONSE
    Publication number: 20120065401
    Abstract: Isolated and purified chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs, are provided.
    Type: Application
    Filed: June 7, 2011
    Publication date: March 15, 2012
    Applicant: Cambridge Enterprise Limited
    Inventors: David J. Grainger, Lauren Marie Tatalick
  • Methods to inhibit or augment an inflammatory response
    Patent number: 7989466
    Abstract: Isolated and purified chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs, are provided.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: August 2, 2011
    Assignee: Cambridge Enterprise Limited
    Inventors: David J. Grainger, Lauren Marie Tatalick
  • Compounds and methods to inhibit or augment an inflammatory response
    Patent number: 7700087
    Abstract: Isolated and purified chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs, are provided. For example, the invention provides peptides of no more than 15 amino acid residues which include chemokine peptide sequences and variants thereof, as well as cyclic reverse derivatives thereof, which inhibit the activity of at least one chemokine.
    Type: Grant
    Filed: September 11, 2002
    Date of Patent: April 20, 2010
    Assignee: Cambridge Enterprise Limited
    Inventors: David J. Grainger, Lauren Marie Tatalick, Suzanne T. Kanaly
  • High dose radionuclide complexes for bone marrow treatment
    Patent number: 7696331
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: April 13, 2010
    Assignee: Poniard Pharmaceuticals, Inc.
    Inventors: Alan R. Fritzberg, Paul G. Abrams, Lauren Marie Tatalick, Kent R. Thoelke, James Kyle Bryan, Mark D. Hylarides, Elizabeth K. John
  • HIGH DOSE RADIONUCLIDE COMPLEXES FOR BONE MARROW TREATMENT
    Publication number: 20090136419
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Application
    Filed: June 19, 2008
    Publication date: May 28, 2009
    Inventors: Alan R. Fritzberg, Paul G. Abrams, Lauren Marie Tatalick, Kent R. Thoelke, James Kyle Bryan, Mark D. Hylarides, Elizabeth K. John
  • Treatment of bone-associated cancers
    Patent number: 7408046
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: August 5, 2008
    Assignee: Poniard Pharmaceuticals, Inc.
    Inventors: Alan R. Fritzberg, Paul G. Abrams, Lauren Marie Tatalick, Kent R. Thoelke, James Kyle Bryan, Mark D. Hylarides, Elizabeth K. John
  • High dose radionuclide complexes for bone marrow suppression
    Patent number: 7378077
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: May 27, 2008
    Assignee: Poniard Pharmaceuticals, Inc.
    Inventors: Alan R. Fritzberg, Lauren Marie Tatalick, Kent R. Thoelke, James Kyle Bryan, Mark D. Hylarides, Elizabeth K. John
  • Compounds and methods to inhibit or augment an inflammatory response
    Patent number: 7238711
    Abstract: Isolated and purified chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs, are provided.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: July 3, 2007
    Assignee: Cambridge University Technical Services Ltd.
    Inventors: David J. Grainger, Lauren Marie Tatalick
  • High dose radionuclide complexes for bone marrow suppression
    Patent number: 7097823
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: August 29, 2006
    Assignee: NEORX Corporation
    Inventors: Alan R. Fritzberg, Paul G. Abrams, Lauren Marie Tatalick, Kent R. Thoelke, James Kyle Bryan, Mark D. Hylarides, Elizabeth K. John
  • High dose radionuclide complexes for bone marrow suppression
    Patent number: 7070759
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Grant
    Filed: January 24, 2005
    Date of Patent: July 4, 2006
    Assignee: NeoRx Corporation
    Inventors: Alan R. Fritzberg, Paul G. Abrams, Lauren Marie Tatalick, Kent R. Thoelke, James Kyle Bryan, Mark D. Hylarides, Elizabeth K. John
  • Compounds and methods to inhibit or augment an inflammatory response
    Patent number: 7067117
    Abstract: Isolated and purified chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs, are provided.
    Type: Grant
    Filed: September 11, 1998
    Date of Patent: June 27, 2006
    Assignee: Cambridge University Technical Services, Ltd.
    Inventors: David J. Grainger, Lauren Marie Tatalick, Suzanne T. Kanaly
  • Compounds and methods to inhibit or augment an inflammatory response
    Patent number: 6989435
    Abstract: Isolated and purified chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs, are provided.
    Type: Grant
    Filed: September 11, 1997
    Date of Patent: January 24, 2006
    Assignee: Cambridge University Technical Services Ltd.
    Inventors: David J. Grainger, Lauren Marie Tatalick
  • High dose radionuclide complexes for bone marrow suppression
    Patent number: 6767531
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: July 27, 2004
    Assignee: NeoRx Corporation
    Inventors: Alan R. Fritzberg, Paul G. Abrams, Lauren Marie Tatalick, Kent R. Thoelke, James Kyle Bryan, Mark D. Hylarides, Elizabeth K. John
  • High dose radionuclide complexes for bone marrow suppression
    Publication number: 20020176818
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Application
    Filed: December 11, 2001
    Publication date: November 28, 2002
    Inventors: Alan R. Fritzberg, Paul G. Abrams, Lauren Marie Tatalick, Kent R. Thoelke, James Kyle Bryan, Mark D. Hylarides, Elizabeth K. John
  • COMPOUNDS AND METHODS TO INHIBIT OR AUGMENT AN INFLAMMATORY RESPONSE
    Publication number: 20010006640
    Abstract: Isolated and purified chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs, are provided.
    Type: Application
    Filed: September 11, 1997
    Publication date: July 5, 2001
    Inventors: DAVID J. GRAINGER, LAUREN MARIE TATALICK